Malignant melanoma brain metastases. Review of roswell park memorial institute experience
- 1 June 1984
- Vol. 53 (11) , 2550-2552
- https://doi.org/10.1002/1097-0142(19840601)53:11<2550::aid-cncr2820531129>3.0.co;2-b
Abstract
One-hundred twenty five of 700 patients with malignant melanoma treated at Roswell Park Memorial Institute from 1972 to 1978 were found to have brain metastases. Seventy-three percent of the patients had multiple brain metastases. Male to female ratio was 1.9:1. The median survival of the untreated group of patients was 3 weeks as compared with that of 6 weeks for the patients maintained on steroids only, 9 weeks for those who received radiotherapy, 11 weeks for the patients treated with intraarterial chemotherapy, and 26 weeks for the patients who underwent successful surgical excision of a solitary lesion.This publication has 5 references indexed in Scilit:
- Phase II study—intra-arterial bcnu therapy for metastatic brain tumorsCancer, 1981
- Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survivalCancer, 1978
- The Diagnostic Limitations of Computerised Axial Tomography in Hemispheric TumoursPublished by Springer Nature ,1978
- Metastatic carcinoma in the central nervous system and dorsal root ganglia.A prospective autopsy studyCancer, 1963
- INTRACRANIL CARCINOMATOUS METASTASES WITH NOTE ON RELATION OF CARCINOMA AND TUBERCLEAnnals of Surgery, 1931